Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228974 | PMC |
http://dx.doi.org/10.4103/ijo.IJO_2284_22 | DOI Listing |
J Opioid Manag
January 2025
Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill; South East Area Health Education Center, College of Nursing, University of North Carolina Wilmington, Wilmington, North Carolina. ORCID: https://orcid.org/0000-0002-7507-0631.
With the Food and Drug Administration's approval of the first over-the-counter naloxone nasal spray in 2023, it was expected that access to naloxone nasal spray would increase and that its cost would be reduced. However, the writers of this commentary found varying insurance coverage of naloxone during purchase attempts at local pharmacies. Failure to cover naloxone can reduce access and increase risk of overdose death.
View Article and Find Full Text PDFInt J Health Policy Manag
December 2024
NCD Alliance, Washington, DC, USA.
Bennett and colleagues' paper aims to synthesize the existing frameworks to identify and monitor unhealthy commodity industry's (UCI's) influence on health "to create a template surveillance system to be used by national governments across industries." In this commentary, we argue that to achieve a robust government-led national surveillance system, some challenges should be considered, such as () addressing power asymmetries between government and UCIs involved in policy-making, () evaluating competing interests among government constituencies to achieve policy coherence around health issues, and () contemplate whether governments rely on private or corporate donors and partners that may threaten financing and operationalization of the surveillance. Suggestions on how to overcome these challenges are beyond the scope of this commentary, but we discuss some cases of bottom-up approaches from organized groups aiming to hold UCIs accountable.
View Article and Find Full Text PDFInt J Health Policy Manag
December 2024
Graduate School of Social Work, University of Denver, Denver, CO, USA.
This commentary joins the chorus of rightful critiques of global health as it continues to further colonial agendas under the guise of supposed well-meaning efforts. Engebretsen and Baker rightfully call out the uptake of decolonial rhetoric in the field of global health, pointing out notable failures to actually challenge undergirding colonial structures and move beyond theory into meaningful action, using clear examples from the ongoing crisis in Gaza and global health's ongoing response (or lack thereof). In this work I bring together essential foundations of decolonial scholarship in order to further the work Engebretsen and Baker have defined as crucial reckoning points for the field of global health.
View Article and Find Full Text PDFTher Innov Regul Sci
January 2025
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
This commentary addresses the recent U.S. Food & Drug Administration (FDA) proposed rule to expand access to nonprescription drugs through additional conditions of nonprescription use (ACNU).
View Article and Find Full Text PDFNat Cardiovasc Res
January 2024
Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, Netherlands.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!